Patient engagement in drug development: configuring a new resource for generating innovation

IF 3.1 3区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Critical Public Health Pub Date : 2023-03-17 DOI:10.1080/09581596.2023.2188140

O. Zvonareva

引用次数: 0

查看原文本刊更多论文

患者参与药物开发:配置产生创新的新资源

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Critical Public Health Multiple-

CiteScore

5.90

自引率

7.10%

发文量

期刊介绍： Critical Public Health (CPH) is a respected peer-review journal for researchers and practitioners working in public health, health promotion and related fields. It brings together international scholarship to provide critical analyses of theory and practice, reviews of literature and explorations of new ways of working. The journal publishes high quality work that is open and critical in perspective and which reports on current research and debates in the field. CPH encourages an interdisciplinary focus and features innovative analyses. It is committed to exploring and debating issues of equity and social justice; in particular, issues of sexism, racism and other forms of oppression.